Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Terra Nova

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Wellness Aromatherapy Citrus Awakening collection includes Ethereal Essential Oil, Aromatic Cologne Mist, Crystal-Clean Glycerin Soaps, Walnut Cleansing Body Scrub and Sheer Aloe & Ginseng Lotion, firm says. Products contain blend of mandarin, neroli, lavender and ylang ylang essential oils. Lavender Calm bath and body collection comprises Ethereal Essential Oil, Aromatic Cologne Mist, Pure & Creamy Glycerin Soaps, Hydrating Sea Spa Body Wash, Hydrotherapy Marine Mineral Salts, Moisture Milk Fluid Body Cream and Relaxing Massage & Body Oil. Formulas fuse lavender, chamomile, rose and calendula essential oils. Products presented in apothecary-style clear bottles, topped with white dispensing or matte silver signature caps, Terra Nova says. Available now, retail prices range from $12 to $30

Table

View full table

Tags:
Latest Headlines

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List

Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

See All
UsernamePublicRestriction

Register

RS009233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By